Real-world incidence and outcomes of immune-related adverse events in NSCLC patients

被引：1
|
作者：
Knox, A. [1 ]
Cloney, T. [1 ]
Janssen, H. [1 ]
Solomon, B. [1 ]
Alexander, M. [2 ]
John, T. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.629
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
551P
引用
收藏
页码：S1684 / S1684
页数：1
相关论文
共 50 条
  • [21] Ophthalmic Immune-Related Adverse Events and Association with Survival: Results From a Real-World Database
    Quiruz, Lee
    Yavari, Negin
    Kikani, Bijal
    Gupta, Ankur Sudhir
    Wai, Karen Michelle
    Kossler, Andrea Lora
    Ludwig, Chase
    Koo, Eubee Baughn
    Rahimy, Ehsan
    Mruthyunjaya, Prithvi
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2024, 268 : 348 - 359
  • [22] Germline variation and risk of immune-related adverse events (irAEs): A real-world BioVU study
    Balko, Justin M.
    Yao, Lydia
    Zhang, Siwei
    Fahey, Catherine
    Haugh, Alexandra
    Davis, Andrea
    Mukherjee, Eric
    Hammer, Christian
    Phillips, Elizabeth J.
    Bejan, Cosmin A.
    Xu, Yaomin
    Johnson, Douglas Buckner
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Immune-related adverse events and outcomes among pan-cancer patients receiving immune checkpoint inhibitors: A monocentric real-world observational study
    Ge, Xiaoxiao
    Jiang, Weiping
    Li, Hongqing
    Wu, Yanxu
    Li, Xiangyang
    Cui, Shaohua
    CANCER MEDICINE, 2023, 12 (18): : 18491 - 18502
  • [24] Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis
    Pasello, Giulia
    Pavan, Alberto
    De Nuzzo, Mattia
    Frega, Stefano
    Ferro, Alessandra
    Dal Maso, Alessandro
    Bonanno, Laura
    Guarneri, Valentina
    Girardi, Fabio
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [25] Immune-related adverse events: Spectrum and clinical features in the real world
    Vieira, I. M.
    Pinelas, S.
    Gaspar, C.
    Dinis, J.
    Oliveira, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1434 - S1434
  • [26] Incidence and outcomes of immune-related adverse events after immune checkpoint inhibitors in patients with Hodgkin lymphoma
    Lin, Cindy
    Tse, William W.
    Wang, Jiasheng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Real-world outcomes of immune-related adverse events in 2,125 patients managed with immunotherapy: A United Kingdom multicenter series.
    Olsson-Brown, Anna Claire
    Baxter, Mark
    Dobeson, Caroline
    Feeney, Laura
    Lee, Rebecca
    Maynard, Alec
    Mirza, Shagufta
    Mughal, Sohail
    Parikh, Shefali
    Rodgers, Lisa Jane
    Salawu, Abdulazeez
    Shotton, Rohan
    Tinsley, Nadina
    Zhao, Sizheng Steven
    Jones, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] ANALYSIS OF IMMUNE RELATED ADVERSE EVENTS IN NSCLC PATIENTS RECEIVING DURVALUMAB AFTER CHEMORADIOTHERAPY IN THE REAL-WORLD CLINICAL SETTING
    Fujita, Kohei
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Nakatani, Koichi
    Mio, Tadashi
    RESPIROLOGY, 2019, 24 : 50 - 50
  • [29] Real-world immune-related adverse events in patients with early triple negative breast cancer who received pembrolizumab
    Jayan, Athira
    Sukumar, Jasmine S.
    Fangman, Benjamin David
    Patel, Tejal Amar
    Raghavendra, Akshara Singareeka
    Liu, Diane D.
    Rauch, Ronald
    Basen-Engquist, Karen
    Tripathy, Debashish
    Barcenas, Carlos Hernando
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Comment on Ophthalmic Immune-Related Adverse Events and Association With Survival: Results From a Real-World Database
    Lum, Flora
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2025, 270 : 277 - 277
12345